Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-023987

Chief Medical Officer sold 9,588 shares at an average $26.35 ($252,678)

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-04-04 Sale : show line 1 in the form −8,155 $26.24 $213,987 114,927 I
2019-04-04 Sale : show line 2 in the form −1,433 $27.00 $38,691 113,494 I
Open-market sales · 9,588 sh · avg $26.35 · $252,678
Loading xslF345X03/doc4.xml…